Stivarga 40 mg film-coated tablets
- Licence status
- Active substances
- Regorafenib
- Dosage Form
- Film-coated tablet
- Licence number
- EU/1/13/858/001-002
- Licence holder
- Bayer Pharma AG
Product documents
Licence information
- ATC code
- L01XE Protein kinase inhibitors, L01XE21 regorafenib
- Legal supply status
- Product subject to prescription which may not be renewed (A)
- Place of sale
- Supply through pharmacies only
- Conditions of Licence
- Medicinal product subject to restricted medical prescription (See Summary of Product Characteristics, section 4.2).
- Marketing availability
- Unknown
- Advertising conditions
- Advertising to healthcare professionals only
- Licence issued